• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factors affecting the absolute bioavailability of nifedipine.影响硝苯地平绝对生物利用度的因素。
Br J Clin Pharmacol. 1995 Jul;40(1):51-8. doi: 10.1111/j.1365-2125.1995.tb04534.x.
2
Ethnic differences in the pharmacokinetics of oral nifedipine.口服硝苯地平药代动力学的种族差异。
Br J Clin Pharmacol. 1991 Apr;31(4):399-403. doi: 10.1111/j.1365-2125.1991.tb05552.x.
3
Ethnic differences in nifedipine kinetics: comparisons between Nigerians, Caucasians and South Asians.硝苯地平动力学的种族差异:尼日利亚人、白种人和南亚人之间的比较。
Br J Clin Pharmacol. 1995 Nov;40(5):489-93.
4
Influence of grapefruit juice on the pharmacokinetics of a slow release nifedipine formulation.
Pharmazie. 1994 Jul;49(7):522-4.
5
Grapefruit juice-nifedipine interaction: possible involvement of several mechanisms.葡萄柚汁与硝苯地平的相互作用:可能涉及多种机制。
J Clin Pharm Ther. 2005 Apr;30(2):153-8. doi: 10.1111/j.1365-2710.2004.00618.x.
6
The influence of dose and ethnic origins on the pharmacokinetics of nifedipine.剂量和种族起源对硝苯地平药代动力学的影响。
Clin Pharmacol Ther. 1993 Sep;54(3):329-38. doi: 10.1038/clpt.1993.155.
7
The pharmacokinetics of oral nifedipine--a population study.口服硝苯地平的药代动力学——一项群体研究。
Br J Clin Pharmacol. 1988 Jun;25(6):701-8. doi: 10.1111/j.1365-2125.1988.tb05256.x.
8
Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice.槲皮素,一种细胞色素P450 3A(CYP3A)的体外抑制剂,并不参与硝苯地平和葡萄柚汁之间的相互作用。
Br J Clin Pharmacol. 1993 Nov;36(5):460-3. doi: 10.1111/j.1365-2125.1993.tb00396.x.
9
Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine.硝苯地平药代动力学和药效学的年龄相关性变化。
Br J Clin Pharmacol. 1988 Mar;25(3):297-305. doi: 10.1111/j.1365-2125.1988.tb03307.x.
10
Pharmacokinetics of nifedipine in Taiwanese.硝苯地平在台湾人群中的药代动力学。
Biopharm Drug Dispos. 2004 Mar;25(2):77-84. doi: 10.1002/bdd.386.

引用本文的文献

1
PBPK/PD Modeling of Nifedipine for Precision Medicine in Pregnant Women: Enhancing Clinical Decision-Making for Optimal Drug Therapy.硝苯地平用于孕妇精准医学的 PBPK/PD 模型:增强临床决策以实现最佳药物治疗。
Pharm Res. 2024 Jan;41(1):63-75. doi: 10.1007/s11095-023-03638-2. Epub 2023 Dec 4.
2
Theoretical Examination Seeking Tangible Physical Meanings of Slopes and Intercepts of Plasma Concentration-Time Relationships in Minimal Physiologically Based Pharmacokinetic Models.理论探讨:最小生理基于药代动力学模型中血浆浓度-时间关系的斜率和截距的有形物理意义。
AAPS J. 2023 Jan 26;25(1):19. doi: 10.1208/s12248-022-00779-x.
3
Determinants of Biological Half-Lives and Terminal Slopes in Physiologically Based Pharmacokinetic Systems: Assessment of Limiting Conditions.生理药代动力学系统中生物半衰期和末端斜率的决定因素:限制条件评估。
AAPS J. 2022 Aug 30;24(5):96. doi: 10.1208/s12248-022-00739-5.
4
Effect of repeated Shengmai-San administration on nifedipine pharmacokinetics and the risk/benefit under co-treatment.重复生脉散给药对硝苯地平药代动力学的影响及合用的风险/获益。
J Food Drug Anal. 2022 Mar 15;30(1):111-127. doi: 10.38212/2224-6614.3401.
5
The Challenge and Importance of Integrating Drug-Nutrient-Genome Interactions in Personalized Cardiovascular Healthcare.在个性化心血管医疗保健中整合药物-营养-基因组相互作用的挑战与重要性。
J Pers Med. 2022 Mar 22;12(4):513. doi: 10.3390/jpm12040513.
6
Inter-ethnic differences in pharmacokinetics-is there more that unites than divides?种族间药代动力学的差异——有更多的共同点还是更多的分歧?
Pharmacol Res Perspect. 2021 Dec;9(6):e00890. doi: 10.1002/prp2.890.
7
The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug-Drug Interactions.用于药物吸收和药物代谢的分离肠内流模型(SFM):对肠和肝脏代谢以及药物-药物相互作用的影响
Pharmaceutics. 2020 Apr 1;12(4):312. doi: 10.3390/pharmaceutics12040312.
8
The BioGIT System: a Valuable In Vitro Tool to Assess the Impact of Dose and Formulation on Early Exposure to Low Solubility Drugs After Oral Administration.BioGIT 系统:一种评估口服给予低溶解度药物后早期暴露于剂量和剂型影响的有价值的体外工具。
AAPS J. 2018 May 24;20(4):71. doi: 10.1208/s12248-018-0231-8.
9
A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.用于预测经多种酶途径代谢的药物在孕妇体内药代动力学的基于生理的药代动力学模型。
Clin Pharmacokinet. 2018 Jun;57(6):749-768. doi: 10.1007/s40262-017-0594-5.
10
Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation.基于对流-扩散方程的连续肠道吸收模型。
Mol Pharm. 2017 Sep 5;14(9):3069-3086. doi: 10.1021/acs.molpharmaceut.7b00286. Epub 2017 Jul 31.

本文引用的文献

1
Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice.槲皮素,一种细胞色素P450 3A(CYP3A)的体外抑制剂,并不参与硝苯地平和葡萄柚汁之间的相互作用。
Br J Clin Pharmacol. 1993 Nov;36(5):460-3. doi: 10.1111/j.1365-2125.1993.tb00396.x.
2
Grapefruit juice--felodipine interaction: mechanism, predictability, and effect of naringin.葡萄柚汁与非洛地平的相互作用:机制、可预测性及柚皮苷的影响
Clin Pharmacol Ther. 1993 Jun;53(6):637-42. doi: 10.1038/clpt.1993.84.
3
Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man.葡萄柚汁及其苦味成分柚皮素对人体中细胞色素P450 1A2介导的咖啡因代谢的抑制作用。
Br J Clin Pharmacol. 1993 Apr;35(4):431-6. doi: 10.1111/j.1365-2125.1993.tb04162.x.
4
The influence of dose and ethnic origins on the pharmacokinetics of nifedipine.剂量和种族起源对硝苯地平药代动力学的影响。
Clin Pharmacol Ther. 1993 Sep;54(3):329-38. doi: 10.1038/clpt.1993.155.
5
Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms.人肝细胞色素P450对咖啡因的代谢:1A2、2E1和3A同工型的作用
Biochem Pharmacol. 1994 May 18;47(10):1767-76. doi: 10.1016/0006-2952(94)90304-2.
6
Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver.细胞色素P450 CYP3A mRNA在胚胎及成人肝脏中的选择性表达。
Pharmacogenetics. 1994 Feb;4(1):11-20. doi: 10.1097/00008571-199402000-00002.
7
Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.
Drug Metab Dispos. 1994 Nov-Dec;22(6):947-55.
8
CYP3A gene expression in human gut epithelium.人肠道上皮细胞中CYP3A基因的表达
Pharmacogenetics. 1994 Oct;4(5):247-59. doi: 10.1097/00008571-199410000-00003.
9
Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids.天然黄酮类化合物对人肝微粒体中苯并(a)芘和黄曲霉毒素B1代谢的激活与抑制作用。
Cancer Res. 1981 Jan;41(1):67-72.
10
Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects.硝苯地平在正常受试者单次静脉注射和口服后的动力学及生物利用度。
J Clin Pharmacol. 1983 Apr;23(4):161-70. doi: 10.1002/j.1552-4604.1983.tb02720.x.

影响硝苯地平绝对生物利用度的因素。

Factors affecting the absolute bioavailability of nifedipine.

作者信息

Rashid T J, Martin U, Clarke H, Waller D G, Renwick A G, George C F

机构信息

Clinical Pharmacology Group, University of Southampton, Bassett Cresent East, UK.

出版信息

Br J Clin Pharmacol. 1995 Jul;40(1):51-8. doi: 10.1111/j.1365-2125.1995.tb04534.x.

DOI:10.1111/j.1365-2125.1995.tb04534.x
PMID:8527268
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1365027/
Abstract
  1. Nifedipine was administered to eight volunteers (seven Caucasian, one East Asian of Chinese origin) as a single 10 mg capsule orally and as 2.5 mg intravenously. The pharmacokinetics were determined under fasting conditions and following 200 ml double strength grapefruit juice taken orally both 2 h before and at the time of dosing. 2. In a separate study, the pharmacokinetics of nifedipine were defined in eight South Asian volunteers (with both parents originating from the Indian subcontinent) following 10 mg nifedipine orally and 2.5 mg intravenously. 3. The administration of grapefruit juice did not alter the pharmacokinetics of intravenous nifedipine, but resulted in a significantly increased area under the plasma concentration-time curve (AUC) (191 +/- 59 c.f. 301 +/- 95 ng ml-1 h, P < 0.05) and bioavailability (0.63 +/- 0.18 c.f. 0.86 +/- 0.15, P < 0.05) following oral nifedipine. The elimination half-life was unchanged by administration of grapefruit juice and there was no evidence of decreased formation of the nitropyridine first-pass metabolite. 4. The AUC of nifedipine after intravenous administration was significantly higher in South Asian subjects than in Caucasians (146 +/- 39 c.f. 74 +/- 18 ng ml-1 h, P < 0.002). This was due to a lower systemic clearance in the South Asians which was 50% of that in the Caucasians. The half-life was markedly prolonged in South Asians (4.1 +/- 1.9 c.f. 1.7 +/- 0.5 h, P < 0.002).(ABSTRACT TRUNCATED AT 250 WORDS)
摘要
  1. 给8名志愿者(7名白种人,1名华裔东亚人)口服10毫克硝苯地平胶囊,并静脉注射2.5毫克硝苯地平。在空腹条件下以及在给药前2小时和给药时口服200毫升双倍浓度葡萄柚汁后测定药代动力学。2. 在另一项研究中,对8名南亚志愿者(父母均来自印度次大陆)口服10毫克硝苯地平和静脉注射2.5毫克硝苯地平后的药代动力学进行了定义。3. 饮用葡萄柚汁并未改变静脉注射硝苯地平的药代动力学,但导致口服硝苯地平后血浆浓度-时间曲线下面积(AUC)显著增加(191±59对比301±95纳克/毫升·小时,P<0.05)和生物利用度增加(0.63±0.18对比0.86±0.15,P<0.05)。葡萄柚汁的摄入未改变消除半衰期,也没有证据表明硝基吡啶首过代谢产物的形成减少。4. 静脉注射后,南亚受试者硝苯地平的AUC显著高于白种人(146±39对比74±18纳克/毫升·小时,P<0.002)。这是由于南亚人的全身清除率较低,仅为白种人的50%。南亚人的半衰期明显延长(4.1±1.9对比1.7±0.5小时,P<0.002)。(摘要截断于250字)